David Marchant, PhD
David Marchant is a Professor in the Department of Medical Microbiology and Immunology at the Â鶹ÊÓƵ. Dr Marchant is also a Canada Research Chair in Viral Pathogenesis and the founder and CSO of Antibiddies Technologies Inc., which is developing a drug called RespVirex. The drug is being formulated into a preventative antiviral nasal spray that can be given to infants and adults with ease. The drugs being developed by his company are derived from his research program at the Â鶹ÊÓƵ that studies respiratory viruses like SARS-CoV-2 and Respiratory Syncytial Virus.